Keith J Sullivan has bought stock on 2 days since May 2018

Keith J. Sullivan is the President and Chief Executive Officer of Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on NeuroStar Advanced Therapy TMS for treating depression.( He joined the company on July 14, 2020, initially as Director and President, and was promoted to CEO on March 7, 2024.( With over 30 years of senior sales and leadership experience in the medical device industry, Sullivan previously held key roles at ZELTIQ Aesthetics, Inc., including Chief Commercial Officer and President (North America) from January 2016 to April 2017 (until its acquisition by Allergan), Senior Vice President and Chief Commercial Officer from November 2014 to January 2016, and Senior Vice President of Worldwide Sales and Marketing from July 2013 to October 2014.( Earlier positions include leadership roles at Medicis Pharmaceuticals, Reliant Technologies, Medtronic, Vision Quest Laser Center, and Coherent Medical.(

Sullivan holds a Bachelor of Business Administration from the College of William and Mary, where he served as Clinical Professor from August 2017 to July 2020.( He currently serves on the Board of Directors of Venus Concept and previously served on the boards of Sientra, Inc. and Cutera, Inc.( Recently, as of February 2026, he sold shares to cover tax obligations on vesting restricted stock units, including 33,847 shares on February 12 and 40,976 shares on February 10.(

Written by Perplexity from public sources.